For Patients

What is a clinical trial? An introduction for patients and families

Clinical trials, sometimes called studies, are a form of research with the involvement of patients.
They are the final step in a long process that begins with research in a laboratory, and there are typically three phases in every clinical trial:

Three phases of a clinical trial

In Phase I, the new treatment is usually given at very low doses in the first instance, because the aim of this phase is primarily to examine how it affects the human body, to find a safe dose and to find how it should be delivered, although in cancer early signs of activity are hoped for.

A Phase I trial is usually fairly small, typically involving 15-30 patients.

In Phase II, the treatment’s effectiveness is studied as well as its side-effects.
Phase II trials involve a larger number of patients than Phase I, but typically it will be less than 100.

In Phase III, the safety and effectiveness of the new treatment is usually tested against an existing optimum treatment or recognised standard of care.

In a Phase III trial, patients are randomly allocated to the various treatment arms, in a process similar to throwing a dice, known as “randomisation.”

The study group is given the new treatment or procedure to be tested; the control group is given an existing optimum treatment which may or not include a placebo.

It is important to understand that patients cannot choose which group they will be allocated to, and that they may not receive the experimental treatment in the trial. Some may receive an inactive drug called a placebo, and this will be explained to you in the information sheet.

A Phase III trial, which typically involves hundreds if not thousands of patients, is a prerequisite for official approval of a new treatment in Europe as this is the only way to evaluate the effectiveness of the new treatment compared to existing treatments.

It should be noted that randomization, typically associated with Phase III trials, is also increasingly used in Phase II trials.

 

Clinical Trials Brochure

ENGOT and ENGAGe have created a brochure specifically tailored to the needs of patients.

You can find the details here:

Webinar on the clinical trial process

A webinar was prepared by ENGOT leading experts for members of  ENGAGe (European Network of gynaecological Cancer Advocacy Groups) with the aim of educating a number of patients from major European countries to a level where they will be able to understand the process of a clinical trial and contribute with useful input from a patient perspective.

Next ENGOT meeting

September 26-27, 2024

Amsterdam, the Netherlands

 

You May Also Like

GCA6

GCA WORKSHOPS

Watch the Webcasts 

 

Read More

background

CLINICAL TRIALS

Latest Published Research

 

Read More

patient2

FOR PATIENTS

Key Insights

 

Read More

ESGO2023_380x206

ESGO 2023 Congress

September 28 - October 1, 2023
Istanbul, Türkiye

Read More